Heartflow (NASDAQ:HTFL) Stock Rating Upgraded by Zacks Research

Heartflow (NASDAQ:HTFL) was upgraded by research analysts at Zacks Research to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.

Other research analysts also recently issued research reports about the company. Canaccord Genuity Group initiated coverage on Heartflow in a report on Tuesday. They set a “buy” rating and a $35.00 target price on the stock. Stifel Nicolaus initiated coverage on Heartflow in a report on Tuesday. They set a “buy” rating and a $35.00 target price on the stock. Wall Street Zen raised Heartflow to a “hold” rating in a report on Saturday, August 16th. Morgan Stanley started coverage on Heartflow in a report on Tuesday. They issued an “equal weight” rating and a $35.00 price target on the stock. Finally, Piper Sandler started coverage on Heartflow in a report on Tuesday. They issued an “overweight” rating and a $38.00 price target on the stock. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Heartflow currently has an average rating of “Moderate Buy” and an average target price of $35.80.

Heartflow Price Performance

NASDAQ:HTFL opened at $34.08 on Wednesday. Heartflow has a 52 week low of $26.56 and a 52 week high of $36.68.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.